A DNA fusion vaccine induces bactericidal antibodies to a peptide epitope from the PorA porin of Neisseria meningitidis

Infection and Immunity

Volumn 76, Issue 1, 2008, Pages 334-338

  Zhu, Delin ^a,b   Williams, Jeannette N ^a   Rice, Jason ^a   Stevenson, Freda K ^a   Heckels, John E ^a   Christodoulides, Myron ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b Amcellgene Co Ltd   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISERUM; DNA VACCINE; PLASMID DNA; PORIN A; RECOMBINANT PROTEIN; TETANUS TOXIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOFLUORESCENCE; IMMUNOSTIMULATION; MOUSE; NEISSERIA MENINGITIDIS; NEISSERIACEAE INFECTION; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL VACCINES; EPITOPES; MENINGOCOCCAL INFECTIONS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NEISSERIA MENINGITIDIS; PLASMIDS; PORINS; VACCINES, DNA;

EID: 37749045246     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.00943-07     Document Type: Article

References (44)

1. Beninati, C., A. Midiri, G. Mancuso, C. Biondo, M. Arigo, E. Gerace, S. Papasergi, M. Gambuzza, M. Boretti, W. Magliani, S. Conti, L. Polonelli, and G. Teti. 2006. Antiidiotypic DNA vaccination induces serum bactericidal activity and protection against group B meningococci. J. Exp. Med. 203:111-118.
2. Bergman, P. J., M. A. Camps-Palau, J. A. McKnight, N. F. Leibman, D. M. Craft, C. Leung, J. Liao, I. Riviere, M. Sadelain, A. E. Hohenhaus, P. Gregor, A. N. Houghton, M. A. Perales, and J. D. Wolchok. 2006. Development of a xenogeneic DNA vaccine program for canine malignant melanoma at the Animal Medical Center. Vaccine 24:4582-4585.
3. Biering, E., S. Villoing, I. Sommerset, and K. E. Christie. 2005. Update on viral vaccines for fish. Dev. Biol. (Basel) 121:97-113.
4. Boyer, J. D., A. D. Cohen, S. Vogt, K. Schumann, B. Nath, L. Ahn, K. Lacy, M. L. Bagarazzi, T. J. Higgins, Y. Baine, R. B. Ciccarelli, R. S. Ginsberg, R. R. MacGregor, and D. B. Weiner. 2000. Vaccination of seronegative volunteers with a human immunodeficiency virus type 1 env/rev DNA vaccine induces antigen-specific proliferation and lymphocyte production of beta-chemokines. J. Infect. Dis. 181:476-483.
5. Christodoulides, M., J. L. Brooks, E. Rattue, and J. E. Heckels. 1998. Immunisation with recombinant class 1 outer membrane protein from Neisseria meningitidis: influence of liposomes and adjuvants on antibody avidity, recognition of native protein and the induction of a bactericidal immune response against meningococci. Microbiology 144:3027-3037.
6. Christodoulides, M., B. T. McGuinness, and J. E. Heckels. 1993. Immunisation with synthetic peptides containing epitopes of the class 1 outer membrane protein of Neisseria meningitidis: production of bactericidal antibodies on immunisation with a cyclic peptide. J. Gen. Microbiol. 139:1729-1738.
7. Chua, K. Y., T. Q. Huangfu, and L. N. Liew. 2006. DNA vaccines and allergic diseases. Clin. Exp. Pharmacol. Physiol. 33:546-550.
8. Dunham, S. P. 2006. Lessons from the cat: Development of vaccines against lentiviruses. Vet. Immunol. Immunopathol. 112:67-77.
9. Fischer, L., J. Minke, N. Dufay, P. Baudu, and J. C. Audonnet. 2003. Rabies DNA vaccine in the horse: strategies to improve serological responses. Vaccine 21:4593-4596.
10. Frasch, C. E., W. D. Zollinger, and J. T. Poolman. 1985. Serotype antigens of Neisseria meningitidis and a proposed scheme for designation of serotypes. Rev. Infect. Dis. 7:504-510.
11. Garapin, A. C., L. Ma, P. Pescher, M. Lagranderie, and G. Marchal. 2001. Mixed immune response induced in rodents by two naked DNA genes coding for mycobacterial glycosylated proteins. Vaccine 19:2830-2841.
12. Gurunathan, S., D. M. Klinman, and R. A. Seder. 2000. DNA vaccines: immunology, application, and optimization. Annu. Rev. Immunol. 18:927-974.
13. Hall, R. A., and A. A. Khromykh. 2004. West Nile virus vaccines. Exp. Opin. Biol. Ther. 4:1295-1305.
14. Heckels, J. E. 1977. The surface properties of Neisseria gonorrhoeae: isolation of the major components of the outer membrane. J. Gen. Microbiol. 99:333-341.
15. Humphries, H., J. Williams, R. Blackstone, K. A. Jolley, H. Yuen, and M. H. J. Christodoulides. 2006. Multivalent liposome-based vaccines containing different serosubtypes of PorA protein induce cross-protective bactericidal immune responses against Neisseria meningitidis. Vaccine 24:35-44.
16. Jolley, K., L. Appleby, J. C. Wright, M. Christodoulides, and J. E. Heckels. 2001. Immunisation with recombinant Opc outer membrane protein from Neisseria meningitidis: influence of sequence variation and levels of expression on the bactericidal immune response against meningococci. Infect. Immun. 69:3809-3916.
17. Jordens, J. Z., J. N. Williams, G. R. Jones, M. Christodoulides, and J. E. Heckels. 2004. Development of immunity to serogroup B meningococci during carriage of Neisseria meningitidis in a cohort of university students. Infect. Immun. 72:6503-6510.
18. King, C. A., M. B. Spellerberg, D. Zhu, J. Rice, S. S. Sahota, A. R. Thompsett, T. J. Hamblin, J. Radl, and F. K. Stevenson. 1998. DNA vaccines with single-chain Fv fused to fragment C of tetanus toxin induce protective immunity against lymphoma and myeloma. Nat. Med. 4:281-286.
19. Kwissa, M., E. B. Lindblad, R. Schirmbeck, and J. Reimann. 2003. Code-livery of a DNA vaccine and a protein vaccine with aluminum phosphate stimulates a potent and multivalent immune response. J. Mol. Med. 81:502-510.
20. Le, T. P., K. M. Coonan, R. C. Hedstrom, Y. Charoenvit, M. Sedegah, J. E. Epstein, S. Kumar, R. Wang, D. L. Doolan, J. D. Maguire, S. E. Parker, P. Hobart, J. Norman, and S. L. Hoffman. 2000. Safety, tolerability and humoral immune responses after intramuscular administration of a malaria DNA vaccine to healthy adult volunteers. Vaccine 18:1893-1901.
21. Lesinski, G. B., S. L. Smithson, N. Srivastava, D. X. Chen, G. Widera, and M. A J. Westerink. 2001. A DNA vaccine encoding a peptide mimic of Streptococcus pneumoniae serotype 4 capsular polysaccharide induces specific anti-carbohydrate antibodies in Balb/c mice. Vaccine 19:1717-1726.
22. Littel-van den Hurk, S., V. Gerdts, B. I. Loehr, R. Pontarollo, R. Rankin, R. Uwiera, and L. A. Babiuk. 2000. Recent advances in the use of DNA vaccines for the treatment of diseases of farmed animals. Adv. Drug Del. Rev. 43:13-28.
23. Liu, M. A., B. Wahren, and G. B. K. Hedestam. 2006. DNA vaccines: recent developments and future possibilities. Hum. Gene Ther. 17:1051-1061.
24. Lo Passo, C., A. Romeo, I. Pernice, P. Donato, A. Midiri, G. Mancuso, M. Arigo, C. Biondo, R. Galbo, S. Papasergi, F. Felici, G. Teti, and C. Beninati. 2007. Peptide mimics of the group B meningococcal capsule induce bactericidal and protective antibodies after immunization. J. Immunol. 178:4417-4423.
25. MacGregor, R. R., J. D. Boyer, K. E. Ugen, K. E. Lacy, S. J. Gluckman, M. L. Bagarazzi, M. A. Chattergoon, Y. Baine, T. J. Higgins, R. B. Ciccarelli, L. R. Coney, R. S. Ginsberg, and D. B. Weiner. 1998. First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response. J. Infect. Dis. 178:92-100.
26. McGuinness, B. T., A. K. Barlow, I. N. Clarke, J. E. Farley, A. Anilionis, J. T. Poolman, and J. E. Heckels. 1990. Deduced amino acid sequences of class 1 protein (porA) from 3 strains of Neisseria meningitidis - synthetic peptides define the epitopes responsible for serosubtype specificity. J. Exp. Med. 171:1871-1882.
27. McGuinness, B. T., I. N. Clarke, P. R. Lambden, A. K. Barlow, J. T. Poolman, D. M. Jones, and J. E. Heckels. 1991. Point mutation in meningococcal porA gene associated with increased endemic disease. Lancet 337:514-517.
28. McGuinness, B. T., P. R. Lambden, and J. E. Heckels. 1993. Class 1 outer membrane protein of Neisseria meningitidis: epitope analysis of the antigenic diversity between strains, implications for subtype definition and molecular epidemiology. Mol. Microbiol. 7:505-514.
29. Price, B. M., D. R. Galloway, N. R. Baker, L. B. Gilleland, J. Staczek, and H. E. Gilleland. 2001. Protection against Pseudomonas aeruginosa chronic lung infection in mice by genetic immunization against outer membrane protein F (OprF) of P. aeruginosa. Infect. Immun. 69:3510-3515.
30. Price, B. M., A. L. Liner, S. Park, S. H. Leppla, A. Mateczun, and D. F. Galloway. 2001. Protection against anthrax lethal toxin challenge by genetic immunization with a plasmid encoding the lethal factor protein. Infect. Immun. 69:4509-4515.
31. Prinz, D. M., S. L. Smithson, T. Kieber-Emmons, and M. A. J. Westerink. 2003. Induction of a protective capsular polysaccharide antibody response to a multiepitope DNA vaccine encoding a peptide mimic of meningococcal serogroup C capsular polysaccharide. Immunology 110:242-249.
32. Sedegah, M., R. Hedstrom, P. Hobart, and S. L. Hoffman. 1994. Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein. Proc. Natl. Acad. Sci. USA 91:9866-9870.
33. Stan, R., J. D. Wolchok, and A. D. Cohen. 2006. DNA vaccines against cancer. Haematol. Oncol. Clin. N. Am. 20:613-636.
34. Stevenson, F. K., J. Rice, and D. L. Zhu. 2004. Tumor vaccines. Adv. Immunol. 82:49-103.
35. van der Ley, P., J. E. Heckels, M. Virji, P. Hoogerhout, and J. T. Poolman. 1991. Topology of outer membrane porins in pathogenic Neisseria spp. Infect. Immun. 59:2963-2971.
36. Vanrompay, D., E. Cox, G. Volckaert, and B. Goddeeris. 1999. Turkeys are protected from infection with Chlamydia psittaci by plasmid DNA vaccination against the major outer membrane protein. Clin. Exp. Immunol. 118: 49-55.
37. Wallich, R., A. Siebers, O. Jahraus, C. Brenner, T. Stehle, and M. M. Simon. 2001. DNA vaccines expressing a fusion product of outer surface proteins A and C from Borrelia burgdorferi induce protective antibodies suitable for prophylaxis but not for resolution of Lyme disease. Infect. Immun. 69:2130-2136.
38. Wang, R., D. L. Doolan, T. P. Le, R. C. Hedstrom, K. M. Coonan, Y. Charoenvit, T. R. Jones, P. Hobart, M. Margalith, J. Ng, W. R. Weiss, M. Sedegah, C. de Taisne, J. A. Norman, and S. L. Hoffman. 1998. Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine. Science 282:476-480.
39. Whalen, R. G., C. Leclerc, E. Deriaud, R. Schirmbeck, J. Reimann, and H. L. Davis. 1995. DNA-mediated immunization to the hepatitis B surface antigen. Activation and entrainment of the immune response. Ann. N. Y. Acad. Sci. 772:64-76.
40. Widera, G., M. Austin, D. Rabussay, C. Goldbeck, S. W. Barnett, M. C. Chen, L. Leung, G. R. Otten, K. Thudium, M. J. Selby, and J. B. Ulmer. 2000. Increased DNA vaccine delivery and immunogenicity by electroporation in vivo. J. Immunol. 164:4635-4640.
41. Wiertz, E. J. H. J., J. A. M. Vangaansvandenbrink, H. Gausepohl, A. Prochnickachalufour, P. Hoogerhout, and J. T. Poolman. 1992. Identification of T-cell epitopes occurring in a meningococcal class 1 outer membrane protein using overlapping peptides assembled with simultaneous multiple peptide synthesis. J. Exp. Med. 176:79-88.
42. Wright, J. C., J. N. Williams, M. Christodoulides, and J. E. Heckels. 2002. Immunization with recombinant PorB outer membrane protein induces a bactericidal immune response against Neisseria meningitidis. Infect. Immun. 70:4028-4034.
43. Zak, K., J. L. Diaz, D. Jackson, and J. E. Heckels. 1984. Antigenic variation during infection with Neisseria gonorrhoeae: detection of antibodies to surface proteins in sera of patients with gonorrhea. J. Infect. Dis. 149:166-173.
44. Zhu, W., C. E. Thomas, and P. F. Sparling. 2004. DNA Immunization of mice with a plasmid encoding Neisseria gonorrhoeae PorB protein by intramuscular injection and epidermal particle bombardment. Vaccine 22:660-669.